Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P21
Within normal range
vs 5Y Ago
-1.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -33.88% |
| Q3 2025 | 37.78% |
| Q2 2025 | 40.67% |
| Q1 2025 | -56.34% |
| Q4 2024 | 27.78% |
| Q3 2024 | 19.85% |
| Q2 2024 | 29.94% |
| Q1 2024 | -33.42% |
| Q4 2023 | 9.66% |
| Q3 2023 | -29.83% |
| Q2 2023 | 48.33% |
| Q1 2023 | -49.91% |
| Q4 2022 | 2.37% |
| Q3 2022 | -4.12% |
| Q2 2022 | 21.88% |
| Q1 2022 | -139.27% |
| Q4 2021 | 17.30% |
| Q3 2021 | -141.74% |
| Q2 2021 | 26.48% |
| Q1 2021 | -64.03% |
| Q4 2020 | 21.88% |
| Q3 2020 | 23.91% |
| Q2 2020 | -132.04% |
| Q1 2020 | 510.71% |
| Q4 2019 | -1.28% |
| Q3 2019 | 0.46% |
| Q2 2019 | 31.60% |
| Q1 2019 | -39.51% |
| Q4 2018 | -33.44% |
| Q3 2018 | 9.98% |
| Q2 2018 | 17.07% |
| Q1 2018 | 10.08% |
| Q4 2017 | -0.78% |
| Q3 2017 | -29.76% |
| Q2 2017 | 15.93% |
| Q1 2017 | -24.34% |
| Q4 2016 | 14.44% |
| Q3 2016 | 16.17% |
| Q2 2016 | -4.63% |
| Q1 2016 | -1201.76% |